Vanguard Group’s ENvue Medical Inc FEED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-274
| Closed | -$17.9K | – | 4298 |
|
|
2024
Q4 | $17.9K | Hold |
274
| – | – | ﹤0.01% | 4264 |
|
|
2024
Q3 | $18.5K | Hold |
274
| – | – | ﹤0.01% | 4306 |
|
|
2024
Q2 | $21.1K | Hold |
274
| – | – | ﹤0.01% | 4356 |
|
|
2024
Q1 | $27.2K | Hold |
274
| – | – | ﹤0.01% | 4369 |
|
|
2023
Q4 | $34.7K | Buy |
274
+16
| +6% | +$1.96K | ﹤0.01% | 4397 |
|
|
2023
Q3 | $56K | Buy |
258
+104
| +68% | +$31K | ﹤0.01% | 4399 |
|
|
2023
Q2 | $58K | Sell |
154
-134
| -47% | -$52.1K | ﹤0.01% | 4444 |
|
|
2023
Q1 | $109K | Sell |
288
-8
| -3% | -$4.31K | ﹤0.01% | 4397 |
|
|
2022
Q4 | $164K | Hold |
296
| – | – | ﹤0.01% | 4339 |
|
|
2022
Q3 | $299K | Hold |
296
| – | – | ﹤0.01% | 4346 |
|
|
2022
Q2 | $410K | Hold |
296
| – | – | ﹤0.01% | 4335 |
|
|
2022
Q1 | $755K | Buy |
296
+103
| +53% | +$194K | ﹤0.01% | 4294 |
|
|
2021
Q4 | $441K | Buy |
193
+46
| +31% | +$137K | ﹤0.01% | 4450 |
|
|
2021
Q3 | $665K | Buy |
147
+7
| +5% | +$31K | ﹤0.01% | 4332 |
|
|
2021
Q2 | $263K | Buy |
140
+53
| +61% | +$107K | ﹤0.01% | 4342 |
|
|
2021
Q1 | $196K | Buy |
+87
| New | +$223K | ﹤0.01% | 4263 |
|
|
2020
Q4 | – | Sell |
-13
| Closed | -$20K | – | 4216 |
|
|
2020
Q3 | $20K | Buy |
+13
| New | +$34.6K | ﹤0.01% | 4096 |
|
|
2019
Q3 | – | Sell |
-6
| Closed | -$41K | – | 4160 |
|
|
2019
Q2 | $41K | Hold |
6
| – | – | ﹤0.01% | 4124 |
|
|
2019
Q1 | $55K | Hold |
6
| – | – | ﹤0.01% | 4057 |
|
|
2018
Q4 | $46K | Buy |
6
+1
| +20% | +$8.36K | ﹤0.01% | 4076 |
|
|
2018
Q3 | $53K | Buy |
+5
| New | +$50.4K | ﹤0.01% | 4123 |
|
Other funds holding FEED
Vanguard Group's FEED Position: Q1 2025 in Review
Vanguard Group sold out of ENvue Medical Inc (FEED) in Q1 2025, closing a stake of 274 shares — an estimated $17.9K sold.
Vanguard Group first reported a position in FEED in Q3 2018 and held it in 21 quarters. The position peaked at $755K in Q1 2022. 4 funds tracked by Wall St. Rank hold FEED as of Q1 2025.
- Vanguard Group reported no remaining ENvue Medical Inc position as of Q1 2025 after selling out during the quarter.
- Vanguard Group sold 274 ENvue Medical Inc shares in Q1 2025, an estimated $17.9K.
- Vanguard Group first reported a position in ENvue Medical Inc in Q3 2018 and held it in 21 quarters.
- Vanguard Group's ENvue Medical Inc position peaked at $755K in Q1 2022.
- 4 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2025.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.